Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily on research and development (R&D) activities. The following information is related to Pharma Inc's second year of operations. Pain Reliever $450,000 $300,000 Weight Loser R&D expenditures (second year) After-tax income Current liabilities Divisional investment 1,365,000 982,000 Cost of capital In the first year, Pain Reliever spent $300,000 on R&D, while Weight Loser spent $150,000. Pharma Inc. estimates that R&D expenditures have a three-year life to be amortized according to the following schedule: 1/6 in the year incurred, 1/3 in the next two years, and 1/6 in the fourth year after the initial spending. Required: Calculate EVA for the two divisions of Pharma Inc. for its second year of operations. 275,000 584,000 $210,000 397,000 23% 23%
Pharma Inc. has two product lines organized as divisions (Pain Reliever and Weight Loser) and spends heavily on research and development (R&D) activities. The following information is related to Pharma Inc's second year of operations. Pain Reliever $450,000 $300,000 Weight Loser R&D expenditures (second year) After-tax income Current liabilities Divisional investment 1,365,000 982,000 Cost of capital In the first year, Pain Reliever spent $300,000 on R&D, while Weight Loser spent $150,000. Pharma Inc. estimates that R&D expenditures have a three-year life to be amortized according to the following schedule: 1/6 in the year incurred, 1/3 in the next two years, and 1/6 in the fourth year after the initial spending. Required: Calculate EVA for the two divisions of Pharma Inc. for its second year of operations. 275,000 584,000 $210,000 397,000 23% 23%
Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
Related questions
Question
![Pharma Inc. has two product lines organized
as divisions (Pain Reliever and Weight Loser)
and spends heavily on research and
development (R&D) activities. The following
information is related to Pharma Inc's second
year of operations.
Pain
Reliever
$450,000 $300,000
Weight
Loser
R&D expenditures
(second year)
After-tax income
Current liabilities
Divisional investment 1,365,000 982,000
Cost of capital
In the first year, Pain Reliever spent $300,000
on R&D, while Weight Loser spent $150,000.
Pharma Inc. estimates that R&D expenditures
have a three-year life to be amortized
according to the following schedule: 1/6 in the
year incurred, 1/3 in the next two years, and
1/6 in the fourth year after the initial
spending.
Required:
Calculate EVA for the two divisions of Pharma
Inc. for its second year of operations.
275,000
584,000
$210,000
397,000
23%
23%](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F453ba339-a77a-4730-a7be-4744fc9fbf80%2F90d297ba-6bea-4fe2-939c-af0634cf64e0%2Fio3ri2j_processed.jpeg&w=3840&q=75)
Transcribed Image Text:Pharma Inc. has two product lines organized
as divisions (Pain Reliever and Weight Loser)
and spends heavily on research and
development (R&D) activities. The following
information is related to Pharma Inc's second
year of operations.
Pain
Reliever
$450,000 $300,000
Weight
Loser
R&D expenditures
(second year)
After-tax income
Current liabilities
Divisional investment 1,365,000 982,000
Cost of capital
In the first year, Pain Reliever spent $300,000
on R&D, while Weight Loser spent $150,000.
Pharma Inc. estimates that R&D expenditures
have a three-year life to be amortized
according to the following schedule: 1/6 in the
year incurred, 1/3 in the next two years, and
1/6 in the fourth year after the initial
spending.
Required:
Calculate EVA for the two divisions of Pharma
Inc. for its second year of operations.
275,000
584,000
$210,000
397,000
23%
23%
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps with 2 images
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.Recommended textbooks for you
![Essentials Of Investments](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781260013924/9781260013924_smallCoverImage.jpg)
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
![FUNDAMENTALS OF CORPORATE FINANCE](https://www.bartleby.com/isbn_cover_images/9781260013962/9781260013962_smallCoverImage.gif)
![Financial Management: Theory & Practice](https://www.bartleby.com/isbn_cover_images/9781337909730/9781337909730_smallCoverImage.gif)
![Essentials Of Investments](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781260013924/9781260013924_smallCoverImage.jpg)
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
![FUNDAMENTALS OF CORPORATE FINANCE](https://www.bartleby.com/isbn_cover_images/9781260013962/9781260013962_smallCoverImage.gif)
![Financial Management: Theory & Practice](https://www.bartleby.com/isbn_cover_images/9781337909730/9781337909730_smallCoverImage.gif)
![Foundations Of Finance](https://www.bartleby.com/isbn_cover_images/9780134897264/9780134897264_smallCoverImage.gif)
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
![Fundamentals of Financial Management (MindTap Cou…](https://www.bartleby.com/isbn_cover_images/9781337395250/9781337395250_smallCoverImage.gif)
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
![Corporate Finance (The Mcgraw-hill/Irwin Series i…](https://www.bartleby.com/isbn_cover_images/9780077861759/9780077861759_smallCoverImage.gif)
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education